Citation Impact
Citing Papers
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model
2007
Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock
2008
Activation of human inflammatory cells by secreted phospholipases A2
2006
Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI
1999
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis
2001
Sepsis biomarkers: a review
2010 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Biology of Secretory Phospholipase A2
2008
Widespread expression of tartrate‐resistant acid phosphatase (Acp 5) in the mouse embryo
2000
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Epidemiology of severe sepsis in Japanese intensive care units: A prospective multicenter study
2013
Current perspectives in muscle invasive bladder cancer
2002
Population-based burden of bloodstream infections in Finland
2012
Prosthetic-Joint Infections
2004 Standout
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Identification of Methicillin‐ResistantStaphylococcus aureusCarriage in Less than 1 Hour during a Hospital Surveillance Program
2005
Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome
2001
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Standout
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
2005
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia
2005
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Skin microbiota: a source of disease or defence?
2008
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis
2008
Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study
2014
Severe Sepsis and Septic Shock
2013 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer
2002
Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients
2006
In Vitro Production of Panton-Valentine Leukocidin among Strains of Methicillin-Resistant Staphylococcus aureus Causing Diverse Infections
2007
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases
2000
The skin microbiome
2011 Standout
Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma
2002
PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma
2009
Antibacterial actions of secreted phospholipases A2. Review
2008
Blockade of Human Group X Secreted Phospholipase A2 (GX-sPLA2)-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA2 Inhibitor
2011
Aptamers as Tools in Molecular Biology and Immunology
1999
Sepsis and septic shock
2018 Standout
Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer
1998
Bladder cancer
2016 Standout
Acne vulgaris
2011 Standout
Bactericidal Group IIA Phospholipase A2 in Serum of Patients with Bacterial Infections
2002
The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting
2009
Purpura Fulminans Due toStaphylococcus aureus
2005
Photodynamic therapy and anti-tumour immunity
2006 Standout
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Assessment of incidence of severe sepsis in Sweden using different ways of abstracting International Classification of Diseases codes: Difficulties with methods and interpretation of results
2010
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
2006
The Pathophysiology and Treatment of Sepsis
2003 Standout
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Clinical management of Staphylococcus aureus bacteraemia
2011
Roles of secretory phospholipases A2 in inflammatory diseases and trauma
2000
Disseminated Intravascular Coagulation
1999 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Impact of Infectious Diseases Specialists and Microbiological Data on the Appropriateness of Antimicrobial Therapy for Bacteremia
1999
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
A novel anti‐inflammatory role for secretory phospholipase A 2 in immune complex‐mediated arthritis
2010
Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels
2006
Intravesical immunoprophylaxis in recurrent superficial bladder cancer (stage T1): Multicenter trial comparing bacille calmette-guérin and interferon-alpha
1997
Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials
2007
The acute respiratory distress syndrome
2012 Standout
Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in the Management of Staphylococcus aureus Bacteremia
2012
Relationship between levels of secreted phospholipase A2 groups IIA and X in the airways and asthma severity
2011
Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2
1994
Epidemiologic Trend of Severe Sepsis in Taiwan From 1997 Through 2006
2010
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
2009
Do Guidelines for Community-Acquired Pneumonia Improve the Cost-Effectiveness of Hospital Care?
2001
Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis
2015
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
Recent Advances in Acne Vulgaris Research: Insights and Clinical Implications
2008
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis
2001
Roles of Group IIA Phospholipase A2 and Complement in Killing of Bacteria by Acute Phase Serum
2005
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
The epidemiology of sepsis in Colombia: A prospective multicenter cohort study in ten university hospitals*
2011
The immunopathogenesis of sepsis
2002 StandoutNature
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Acute Lung Injury and the Acute Respiratory Distress Syndrome
2005
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Aptamers: An Emerging Class of Therapeutics
2005
BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS
2005
Functional Nucleic Acid Sensors
2009 Standout
RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER
1998
Assessment of Clinical Criteria for Sepsis
2016 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Isolation of high-affinity GTP aptamers from partially structured RNA libraries
2002 StandoutNobel
Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
2008
A comparison of different antibiotic regimens for the treatment of infective endocarditis
2016
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
High-Affinity Aptamers Selectively Inhibit Human Nonpancreatic Secretory Phospholipase A2 (hnps-PLA2)
1998
Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
2018
Advances in the laboratory diagnosis of prosthetic joint infection
2003
Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the Bladder
1995
5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMA
1999
The epidemiology of sepsis in a Brazilian teaching hospital
2010
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Bladder Cancer
2020 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
2016
The epidemiology of sepsis in a Brazilian teaching hospital
2010
Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.
1996
Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells
2001
Cytokine Storm
2020 Standout
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Protection by Group II Phospholipase A2 Against Staphylococcus aureus
1999
TRACP Influences Th1 Pathways by Affecting Dendritic Cell Function
2006 StandoutNobel
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer
2011
Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice
2010
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
2000
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
HDL Remodeling During the Acute Phase Response
2008
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Prophylaxis For Recurrent Papillary (Stages Ta to T1) Superficial Bladder Cancer
1996
Lipopolysaccharide Endotoxins
2002 Standout
Secretory Phospholipase A 2 Is the Principal Bactericide for Staphylococci and Other Gram-Positive Bacteria in Human Tears
1998
Secretion of group 2 phospholipase A2 by lacrimal glands.
1994
Interleukin‐1‐Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase‐2
1994
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group.
1995
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 Cases
1997
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study
2013
Group II PLA(2) content of tears in normal subjects.
2001
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
2002 Standout
Tartrate‐resistant acid phosphatase: a potential target for therapeutic gold
2004
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality.
2012
Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality
2012
Works of Esa Rintala being referenced
Antimicrobial Therapy of Septicemic Patients in Intensive Care Units before and after Blood Culture Reporting
1991
Synovial‐type (group II) phospholipase A2 in serum of febrile patients with haematological malignancy
1993
Protein C substitution in sepsis-associated purpura fulminans
2000
Role of plasma bactericidal/permeability-increasing protein, group IIA phospholipase A2, C-reactive protein, and white blood cell count in the early detection of severe sepsis in the emergency department
2012
Protein C in the treatment of coagulopathy in meningococcal disease
1998
Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy(Bacillus Calmette-Guérin) in Superficial Bladder Cancer
1991
Late steroid therapy in primary acute lung injury
2000
Value of measurement of C-reactive protein in febrile patients with hematological malignancies
1992
Incidence and Clinical Significance of Positive Blood Cultures in Febrile Episodes of Patients with Hematological Malignancies
1994
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients
2005
Cytostatic effect of different strains of Bacillus Calmette-Gu�rin on human bladder cancer cells in vitro alone and in combination with mitomycin C and Interferon-?
1992
Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
2007
Group II Phospholipase A2 in Sera of Febrile Patients with Microbiologically or Clinically Documented Infections
1993
Immunochemical Detection of Group I and Group II Phospholipases A2 in Human Serum
1992
Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group.
1996
Neoadjuvant Chemotherapy in Bladder Cancer: A Randomized Study
1993
Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
1995
Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.
1996
Synovial fluid acid phosphatase in seropositive and seronegative arthritides.
1990
Elimination of Epidemic Methicillin-ResistantStaphylococcus aureusfrom a University Hospital and District Institutions, Finland
2003
Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome.
1996
Diagnosis of Meningococcal Meningitis by Broad-Range Bacterial PCR with Cerebrospinal Fluid
1998
Early identification of bacteremia by biochemical markers of systemic inflammation
2001
Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum
2005
Protein C in the treatment of coagulopathy in meningococcal disease
1996